menerba

  1. T

    Bionovo Initiates Menerba (MF101) Phase 3 Clinical Trial For Menopausal Hot Flashes

    Bionovo, Inc. (Nasdaq: BNVI), a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, announced that enrollment has started to the Phase 3 pivotal clinical trial evaluating the safety and efficacy of two doses of Menerba™...
  2. T

    FDA Approves Manufacturing Plan For Menerba, Bionovo's Menopausal Hot Flash Drug Cand

    Bionovo, Inc. (Nasdaq: BNVI, BNVID) announced that the U.S. Food and Drug Administration (FDA) accepted the Company's Chemistry, Manufacturing and Controls (CMC) plan for its lead drug candidate, Menerba®, in a Type "B" or "End of Phase 2" meeting. With this designation, the decisions and...
Back
Top